propranolol has been researched along with carbidopa in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (50.00) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 1 (3.85) | 29.6817 |
| 2010's | 9 (34.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Agnoli, A; Carolei, A; Casacchia, M; Fazio, C; Zamponi, A | 1 |
| Fahn, S | 1 |
| Blair, ML; Ganong, WF; Keil, LC; Reid, IA | 1 |
| Grimm, W; Schönberger, W; Ziegler, R | 1 |
| Altszuler, N; Hampshire, J; Moraru, E | 1 |
| McKinney, AS | 1 |
| Cooper, RL; Linnoila, M | 1 |
| Antonaccio, MJ; Kerwin, L | 1 |
| Goshima, Y; Misu, Y; Nakamura, S | 1 |
| De Souza, RJ; Goodwin, GM; Green, AR; Wood, AJ | 1 |
| Herbster, G; Koller, WC | 1 |
| Andermann, E; Andermann, F; Boileau, J; Carpenter, S; Nelson, R; Patry, G; Wolfe, LS | 1 |
| Friedman, E; Gershon, S | 1 |
| Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Donat, J; Gerrard, JW; Richardson, JS | 1 |
| Ahlskog, JE | 1 |
| Grimm, W; Koffler, T; Philippi, H; Pohlenz, J; Schönberger, W | 1 |
| Augustin, S; Brull, A; Coll, M; Esteban, R; Ezkurdia, N; Genescà, J; Guardia, J; Martell, M; Raurell, I; Rodriguez, S | 1 |
2 review(s) available for propranolol and carbidopa
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Medical treatment of later-stage motor problems of Parkinson disease.
Topics: Amantadine; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cholinergic Antagonists; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Humans; Levodopa; Nitriles; Nitrophenols; Parkinson Disease, Secondary; Propranolol; Randomized Controlled Trials as Topic; Selegiline; Tolcapone | 1999 |
1 trial(s) available for propranolol and carbidopa
| Article | Year |
|---|---|
Adjuvant therapy of parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Carbidopa; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Primidone; Propranolol; Random Allocation; Tremor; Trihexyphenidyl | 1987 |
23 other study(ies) available for propranolol and carbidopa
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Therapy of Parkinson's disease. Practical criteria of treatment].
Topics: Amantadine; Antiparkinson Agents; Benserazide; Carbidopa; Cyproheptadine; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piribedil; Pizotyline; Propranolol | 1976 |
New approaches in the management of hyperkinetic movement disorders.
Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclonus; Propranolol; Receptors, Dopamine; Torticollis; Tranquilizing Agents; Tremor | 1977 |
Role of peripheral adrenoreceptors and vasopressin in the suppression of plasma renin activity by L-dopa in carbidopa-treated dogs.
Topics: Animals; Carbidopa; Dogs; Drug Interactions; Female; Levodopa; Male; Phenoxybenzamine; Propranolol; Receptors, Adrenergic; Renin; Vasopressins | 1979 |
[Improvement of growth-hormone stimulation with l-dopa/l-carbidopa by simultaneous administration of propranolol (author's transl)].
Topics: Carbidopa; Child; Dihydroxyphenylalanine; Drug Therapy, Combination; Dwarfism; Growth Hormone; Humans; Propranolol | 1979 |
On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
Topics: Animals; Blood Glucose; Carbidopa; Dogs; Glucose; Growth Hormone; Hydrocortisone; Levodopa; Liver; Phentolamine; Pimozide; Propranolol; Stress, Physiological; Time Factors | 1978 |
The shaking patient. Diagnosis and management of tremor.
Topics: Amantadine; Carbidopa; Cerebellar Diseases; Humans; Levodopa; Parkinson Disease; Propranolol; Tremor | 1977 |
Reinstatement of vaginal cycles in aged female rats.
Topics: Aging; Animals; Benserazide; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Estrus; Female; Fusaric Acid; Hypophysectomy; Levodopa; Phenoxybenzamine; Pimozide; Pregnancy; Propranolol; Rats; Tyrosine; Vagina | 1976 |
Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
Topics: Animals; Atropine; Benserazide; Blood Pressure; Carbidopa; Dogs; Dopamine; Drug Interactions; Female; Levodopa; Male; Monoamine Oxidase Inhibitors; Norepinephrine; Phentolamine; Pressoreceptors; Propranolol; Vagus Nerve | 1976 |
L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
Topics: Animals; Binding, Competitive; Carbidopa; Cocaine; Hydrazines; Hypothalamus; In Vitro Techniques; Levodopa; Norepinephrine; Propranolol; Rats; Structure-Activity Relationship; Sulpiride | 1991 |
The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Body Temperature; Carbidopa; Drug Synergism; Fenclonine; Indoles; Lithium; Male; Methoxydimethyltryptamines; Motor Activity; Naphthalenes; Propranolol; Rats; Rats, Inbred Strains; Receptors, Serotonin; Tetrahydronaphthalenes | 1986 |
Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology.
Topics: Adult; Brain; Carbidopa; Electroencephalography; Electromyography; Female; Humans; Kidney Failure, Chronic; Male; Microscopy, Electron; Myoclonus; Pedigree; Propranolol; Syndrome; Tryptophan | 1986 |
L-DOPA: centrally mediated emission of seminal fluid in male rats.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Atropine; Benserazide; Carbidopa; Cyproheptadine; Dihydroxyphenylalanine; Dopamine; Ejaculation; Haloperidol; Hydrazines; Hypophysectomy; Lysergic Acid Diethylamide; Male; Melatonin; Methysergide; Norepinephrine; Phentolamine; Propranolol; Rats; Semen; Serotonin | 1972 |
The pharmacology of olivopontocerebellar atrophy.
Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; Levodopa; Male; Middle Aged; Olivary Nucleus; Pons; Propranolol; Syndrome | 1984 |
Neuropharmacological evaluation of movement disorders that are adverse reactions to specific foods.
Topics: Adult; Animals; Aspartame; Carbidopa; Coffee; Diazepam; Double-Blind Method; Eggs; Female; Food Hypersensitivity; Haloperidol; Humans; Male; Milk; Milk Hypersensitivity; Movement Disorders; Propranolol; Single-Blind Method; Theophylline; Videotape Recording | 1994 |
Simultaneous stimulation of growth hormone, adrenocorticotropin and cortisol with L-dopa/L-carbidopa and propranolol in children of short stature.
Topics: Adolescent; Adrenocorticotropic Hormone; Carbidopa; Child; Child, Preschool; Dopamine Agents; Drug Synergism; Female; Growth Disorders; Growth Hormone; Humans; Hydrocortisone; Levodopa; Male; Pituitary Function Tests; Propranolol | 2000 |
Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Topics: Animals; Antiparkinson Agents; Bile Ducts; Blood Pressure; Carbidopa; Carbon Tetrachloride; Disease Models, Animal; Diuresis; Droxidopa; Enzyme Inhibitors; Hemodynamics; Hypertension, Portal; Ligation; Liver Cirrhosis; Male; Natriuresis; Nitric Oxide Synthase Type III; Phosphorylation; Portal Vein; Propranolol; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation; rho-Associated Kinases; Signal Transduction; Urodynamics; Vascular Resistance | 2012 |